Dow Down 0.28% Nasdaq Down 0.45%

Imprimis Pharmaceuticals, Inc. (IMMY)

-NasdaqCM
7.60 0.00(0.00%) 9:30AM EDT - Nasdaq Real Time Price
Prev Close:7.60
Open:7.60
Bid:7.50 x 100
Ask:7.60 x 500
1y Target Est:2.00
Beta:-1.85
Next Earnings Date:N/A
Day's Range:7.60 - 7.60
52wk Range:3.01 - 9.62
Volume:64
Avg Vol (3m):22,798
Market Cap:69.39M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMY

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):102.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-10) :N/A
Quarterly EPS Est (Dec-10) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Imprimis Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focusing on the commercial development of compounded drug formulations. The company, through a strategic relationship with Professional Compounding Centers of America, I... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback